Employee Benefit Plans (Tables)

12 Months Ended

Mar. 31, 2024

Share-Based Payment Arrangement [Abstract]

Schedule of Activity With Respect to Stock Options

A summary of activity in the Omnibus Incentive Plans with respect to our stock options for Fiscal 2024 is as follows:

	Options	Weighted Average Exercise Price Per Share		Weighted Average Remaining Contractual Life	Aggregate Intrinsic Value
	(In thousands)			(Years)	(In thousands)
Options outstanding at March 31, 2023	6,287	$	4.11
Granted	475	4.13
Exercised	(173)	3.03
Forfeited	(417)	4.04
Expired	(314)	4.77
Options outstanding at March 31, 2024	5,858	4.11		5.5	$	5,410
Options vested and exercisable at March 31, 2024	4,268	4.16		4.4	$	3,879

Schedule of Activity With Respect to RSUs

A summary of activity with respect to our RSUs for Fiscal 2024 is as follows:

	# of Shares	Weighted Average Price Per Share
	(In thousands)
RSUs outstanding at March 31, 2023	497	$	3.05
Granted	460	4.35
Vested and released	(118)	3.85
Forfeited	(46)	4.12
RSUs outstanding at March 31, 2024	793	4.18

Schedule of the Details of Performance Stock Units

The following table summarizes the details of the performance stock units:

	# of Shares	Weighted Average Price Per Share
	(In thousands)
PSUs outstanding at March 31, 2023	83	$	4.45
Granted	119	4.57
Vested	(43)	5.59
Forfeited	(42)	5.46
PSUs outstanding at March 31, 2024	117	4.75

Schedule of Stock-based Compensation Expense

The following table presents stock-based compensation expense that is included in each functional line item in our statements of operations:

	Year Ended March 31,
	2024		2023
	(In thousands)
Cost of revenues	$	315	$	352
General and administrative	1,596		1,626
Sales and marketing	579		477
Research and development expense	475		435
Total stock-based compensation	$	2,965	$	2,890

Schedule of Weighted-average Assumptions Used in Estimating the Grant Date Fair Value of Stock Options Granted

The grant date fair value of stock options granted was estimated using the following weighted-average assumptions:

	Year Ended March 31,
	2024		2023
Expected life—years	6.3		7.5
Risk-free interest rate	4.2	%	3.6	%
Expected volatility of common stock	52	%	51	%
Dividend yield	0	%	0	%

Schedule of Certain Fair Value and Intrinsic Value Information Pertaining to Stock Options

A summary of certain fair value and intrinsic value information pertaining to our stock options is as follows:

	Year Ended March 31,
	2024		2023
	(In thousands, except per share amounts)
Weighted average grant date fair value per share of options granted	$	2.34	$	1.67
Intrinsic value of options exercised	$	254	$	141